Delivery Order SPE2DB22D3301-SPE2DB24FZ2TD

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,938.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565110719 ! LIDOCAINE 5% PATCH 30S, a pharmaceutical product, and has an ultimate completion date of July 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating...
This federal contract award, valued at $9,856.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, and has an ultimate completion date of July 29, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
This federal contract award, valued at $3,980.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4565618343 ! LIDOCAINE 5% PATCH 30S, with an ultimate completion date of August 29, 2024. The contract type is Firm Fixed Price. This award is not associated with any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565134604 - LIDOCAINE 5% PATCH 30S to the U.S. government. The contract, valued at $2,774.30, was awarded on July 12, 2024 with a completion date of July 15, 2024. It is a firm fixed price delivery order contract issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major agency within the Department of Defense (DoD) responsible for providing logistics and supply chain...
This federal contract award, with a value of $2,861.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of May 21, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,082.49, is for the delivery of 4563867434 ! LIDOCAINE 5% PATCH 30S medical supplies. The contract has an ultimate completion date of March 6, 2024 and is classified as a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of LIDOCAINE 5% PATCH 30S. The contract has an award value of $1,500.80 and a completion date of March 27, 2025. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $2,438.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567898916 - LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of April 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,027.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LIDOCAINE 5% PATCH 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date is August 13, 2024. The contract does not have a set-aside designation. As a significant supplier of pharmaceutical products and medical supplies to the U.S. government, Amerisourcebergen...
This federal contract award, valued at $1,525.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567615853 - LIDOCAINE 5% PATCH 30S, a medical product, with a period of performance through March 19, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing mechanism. This award does not have a set-aside designation, indicating open...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2TD
    Delivery Order

This federal contract award, valued at $3,889.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565427458 - LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 13, 2024. This award is not associated with a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various defense and civilian agencies through numerous contract awards. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for delivering a comprehensive range of medical commodities to government healthcare programs and facilities.

Generated 11/11/24, 9:25 AM